H-Index
79
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
16%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo

Medical Science Monitor Basic Research
AmJCaseRep

Annals
ISI-Home

eISSN: 1643-3750

Is lipoxins A4 a better alternative to anti-VEGF and anti-TNF-alpha antibody to prevent and treat age-related macular degeneration, diabetic macular edema and retinopathy?

Undurti N. Das

Med Sci Monit 2012; 18(1): LE1-2

DOI: 10.12659/MSM.882187

Available online: 2011-12-22

Published: 2011-12-22



Keywords: Macular Degeneration - prevention & control, Lipoxins - therapeutic use, Macular Edema - prevention & control, Diabetic Retinopathy - prevention & control, Antibodies - therapeutic use



Back